Real-world persistence, adherence, health care resource utilization, and costs in people with type 2 diabetes switching from a first-generation basal insulin to a second-generation (insulin glargine 300 U/mL) vs an alternative first-generation basal insulin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world persistence, adherence, health care resource utilization, and costs in people with type 2 diabetes switching from a first-generation basal insulin to a second-generation (insulin glargine 300 U/mL) vs an alternative first-generation basal insulin

Published:2022-03-30 Issue: Volume: Page:1-12
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Wright Eugene E¹,Malone Daniel C²,Trujillo Jennifer M³,Gill Jasvinder⁴,Huse Samuel⁵,Li Xuan⁴,Zhou Fang Liz⁴,Preblick Ron⁴,Reid Timothy⁶

Affiliation:

1. Charlotte Area Health Education Center, Charlotte, NC.

2. Skaggs College of Pharmacy, University of Utah, Salt Lake City.

3. Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora.

4. Sanofi US, Bridgewater, NJ.

5. Evidera, Lexington, MA.

6. Diabetes Center at Mercyhealth System, Janesville, WI.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Reference33 articles.

1. Economic Costs of Diabetes in the U.S. in 2017

2. Insulin Access and Affordability Working Group: Conclusions and Recommendations

3. Switching basal insulins in type 2 diabetes: practical recommendations for health care providers

4. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors

5. Self-reported Barriers to Adherence and Persistence to Treatment With Injectable Medications for Type 2 Diabetes

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. You may delay, but time will not. Beta cells lost are never found again: a case for timely initiation of basal insulin in type 2 diabetes;Postgraduate Medicine;2024-02-17

2. Quantification of insulin adherence in adults with insulin-treated type 2 diabetes: A systematic review;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2023-12

3. The prevalence of adherence to insulin therapy in patients with diabetes: A systematic review and meta-analysis;Research in Social and Administrative Pharmacy;2023-12

4. The economic value of insulin glargine 300 U/mL (Gla-300) in people ≥18 years of age with type 2 diabetes mellitus: a value-based economic model from a U.S. payer perspective;Journal of Medical Economics;2023-11-11

5. Clinical impact after implementing an insulin protocol involving a switch to insulin glargine 300 U/ml as basal insulin for inpatient glycaemic control: A retrospective single-centre study;Journal of Diabetes and its Complications;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3